JP2011511625A5 - - Google Patents

Download PDF

Info

Publication number
JP2011511625A5
JP2011511625A5 JP2010543378A JP2010543378A JP2011511625A5 JP 2011511625 A5 JP2011511625 A5 JP 2011511625A5 JP 2010543378 A JP2010543378 A JP 2010543378A JP 2010543378 A JP2010543378 A JP 2010543378A JP 2011511625 A5 JP2011511625 A5 JP 2011511625A5
Authority
JP
Japan
Prior art keywords
seq
tucap
tumor
protein
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010543378A
Other languages
English (en)
Japanese (ja)
Other versions
JP5752419B2 (ja
JP2011511625A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EE2009/000001 external-priority patent/WO2009092385A1/en
Publication of JP2011511625A publication Critical patent/JP2011511625A/ja
Publication of JP2011511625A5 publication Critical patent/JP2011511625A5/ja
Application granted granted Critical
Publication of JP5752419B2 publication Critical patent/JP5752419B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010543378A 2008-01-25 2009-01-26 新規ヒト転移性腫瘍関連分子、活性化遺伝子およびタンパク質を検出する方法ならびに遺伝子発現を妨害する方法 Expired - Fee Related JP5752419B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6245308P 2008-01-25 2008-01-25
US61/062,453 2008-01-25
PCT/EE2009/000001 WO2009092385A1 (en) 2008-01-25 2009-01-26 A new metastatic human tumor associated molecule, methods to detect both activated gene and protein and to interfere with gene expression

Publications (3)

Publication Number Publication Date
JP2011511625A JP2011511625A (ja) 2011-04-14
JP2011511625A5 true JP2011511625A5 (https=) 2012-02-16
JP5752419B2 JP5752419B2 (ja) 2015-07-22

Family

ID=40527972

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010543378A Expired - Fee Related JP5752419B2 (ja) 2008-01-25 2009-01-26 新規ヒト転移性腫瘍関連分子、活性化遺伝子およびタンパク質を検出する方法ならびに遺伝子発現を妨害する方法

Country Status (12)

Country Link
US (1) US8097407B2 (https=)
EP (1) EP2245465B1 (https=)
JP (1) JP5752419B2 (https=)
CN (1) CN102016587B (https=)
AU (1) AU2009207926B2 (https=)
BR (1) BRPI0906681A2 (https=)
CA (1) CA2713193C (https=)
ES (1) ES2587055T3 (https=)
MX (1) MX2010008163A (https=)
PL (1) PL2245465T3 (https=)
RU (1) RU2546000C2 (https=)
WO (1) WO2009092385A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120122118A1 (en) * 2008-01-25 2012-05-17 Primm Srl Monclonal antibodies, hybridomas and methods for use
EP2467392A4 (en) * 2009-08-17 2013-06-19 Nox Technologies Inc CLONING AND EXPRESSION OF 9-DOMAIN SUPERFAMILY OF ARNOX TRANSMEMBRANE PROTEINS, METHODS AND UTILITY
JP6187939B2 (ja) * 2012-03-08 2017-08-30 学校法人産業医科大学 がんの悪性度の試験方法、ならびに多能性を有する造腫瘍細胞およびその調製方法
WO2015185730A2 (en) * 2014-06-06 2015-12-10 Hansabiomed Ou Exosomal biomarkers
CN105675378A (zh) * 2014-11-18 2016-06-15 上海张江转化医学研发中心有限公司 一种简单的分离单个循环肿瘤细胞的方法和装置
JP6573351B2 (ja) 2017-05-29 2019-09-11 国立大学法人神戸大学 検出対象の分析用センサ作製用基材、検出対象の分析用センサ、及び検出対象の分析法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030175787A1 (en) * 1997-10-28 2003-09-18 Incyte Corporation Vesicle membrane proteins
US20030008356A1 (en) * 1998-08-07 2003-01-09 Ono Pharmaceutical Co., Ltd. Novel polypeptide, a cDNA encoding the same, and use of it
WO2000008056A1 (fr) * 1998-08-07 2000-02-17 Ono Pharmaceutical Co., Ltd. NOUVEAU POLYPEPTIDE, ADNc LE CODANT ET SON UTILISATION
US20070224201A1 (en) * 2002-10-02 2007-09-27 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
WO2005108415A2 (en) * 2004-04-30 2005-11-17 Biogen Idec Ma Inc. Membrane associated molecules
WO2006110593A2 (en) * 2005-04-07 2006-10-19 Macrogenics, Inc. Biological targets for the diagnosis, treatment and prevention of cancer

Similar Documents

Publication Publication Date Title
RU2504551C2 (ru) Белки, связывающие антиген фактор роста, подобный гепаринсвязывающему эпидермальному фактору роста
JP5631733B2 (ja) 抗ＥｐＣＡＭ抗体およびその使用
CN106084052A (zh) 抗cd47单克隆抗体及其应用
NZ597067A (en) Monoclonal antibodies expressed by ATCC PTA-4621 for the treatment of cancer
CN112513094A (zh) 结合人her2的抗体、其制备方法和用途
CN110914304A (zh) Cd96抗体、其抗原结合片段及医药用途
RU2015142815A (ru) Лечение рака с использованием антител, связывающихся с поверхностным grp78
CN113227148B (zh) 抗gpc3抗体、其抗原结合片段及其医药用途
JP2011511625A5 (https=)
CN112094348B (zh) 抗人Tim3抗体或其功能性片段及其应用
CN109867723B (zh) 抗人il6单克隆抗体及其制备方法和用途
CN112243443B (zh) 抗trop-2抗体、其抗原结合片段及其医药用途
EP3992211A1 (en) Anti-cea antibody and application thereof
CN105504060B (zh) 一种抗胃癌细胞表面功能性表达的足萼样蛋白前体亚型2的单克隆抗体及其制备方法和用途
RU2010135525A (ru) Новая ассоциированная с метастатической опухолью человека молекула, способы детекции как активированного гена, так и белка и препятствования экспрессии генов
WO2021213245A1 (zh) 抗体或其抗原结合片段、其制备方法及医药用途
KR20250042144A (ko) Itga2를 표적으로 하는 항체 및 이를 포함하는 항체-약물 접합체(antibody targeting itga2 and antibody-drug conjugate comprising the same)
CN103265631B (zh) 一种抗人crt单克隆抗体的重链和轻链可变区
CN110835372B (zh) 一种靶向Frizzled7单克隆抗体及其制备方法与应用
CN101585880B (zh) 一种抗人IL-13Rα2单克隆抗体的重链和轻链的可变区
CN113597432B (zh) 抗EpCAM抗体及其应用
CN120535630B (zh) 一种靶向cdh17的大羊驼纳米抗体、结合分子及其应用
CN120535623B (zh) Cdh17结合分子及其用途
HK40049006B (en) Anti-gpc3 antibody, antigen-binding fragment thereof, and medical use thereof
CN106749661A (zh) 抗psmp的单克隆抗体及其用途